Business Context and Reporting Period
This Form 8-K Current Report was filed by AtriCure, Inc. on January 4, 2007, covering events occurring on January 5, 2007, and announced on January 9, 2007. The filing discloses the entry into a material definitive employment agreement with a new executive officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation terms:
- Base Salary: $225,000 per year.
- Annual Bonus: Eligible for a year-end bonus with a minimum potential of 30% of base salary.
- Equity Grant: Option to purchase 100,000 shares of common stock under the 2005 Equity Incentive Plan at fair market value on the grant date.
- Relocation Assistance: Reimbursement up to $100,000 for out-of-pocket expenses, subject to repayment if employment is voluntarily terminated within two years.
Material Changes
The primary material change is the appointment of Julie A. Piton as Vice President of Finance and Administration and Chief Financial Officer, commencing employment on January 23, 2007. This represents a change in principal officers and the establishment of new compensatory arrangements.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business performance. Key contractual terms and contingencies include:
- Termination Provisions: Employment may be terminated by either party at any time for any reason. Voluntary termination by the executive requires 45 days' notice.
- Severance: In the event of termination without cause or resignation for good reason, the executive is entitled to six months of base salary. If such termination occurs during a change of control period, severance includes six months of base salary plus the full bonus potential for the year.
- Relocation Requirement: The executive must relocate within a 50-mile radius of the principal office within six months of the start date.
Investor Verification Checklist
- Verify the exact grant date and exercise price of the 100,000 stock options in the full Employment Agreement (Exhibit 10.1).
- Confirm the definitions of "Without Cause" and "Good Reason" to understand the specific triggers for severance payments.
- Review the press release (Exhibit 99.1) for additional context on the strategic rationale for the CFO appointment.
- Check subsequent filings for the actual vesting schedule of the stock options, which is not detailed in this summary text.